Analyst Buzz: AstraZeneca PLC (NYSE:AZN)


AstraZeneca PLC (NYSE:AZN) currently has a “Hold” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

AstraZeneca PLC (NYSE:AZN) gained 4.29 Percent and closed its previous trading session at $36.96. The stock traded with the average Volume of 3.68 Million at the end of last session.

AstraZeneca PLC (NYSE:AZN) has the Market Capitalization of 93.58 Billion. The Stock has its 52-week High of $37.30 and 52-Week Low of $28.43 and it touched its 52-week high on 05/22/18 and 52-Week Low on 07/27/17


The company reported its last earnings Actual EPS of $0.24/share. While, the analyst predicted that the company could provide an EPS of $0.34/share. Hence the difference between Predicted EPS and Actual EPS reported is $-0.1/share which shows an Earnings Surprise of -29.4 Percent.

Sell side analysts plays vital role in buying and selling a stock where 6 analysts rated AstraZeneca PLC (NYSE:AZN) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 1 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.41% where SMA50 and SMA200 are 2.67% and 6.31% respectively.

The company shows its Return on Assets (ROA) value of 4.4%. The Return on Equity (ROE) value stands at 20.3%. While it’s Return on Investment (ROI) value is 13.3%.

AstraZeneca PLC (NYSE:AZN) currently has a Weekly Volatility of 1.11% percent while its Monthly Volatility is at 1.10% percent. While talking about Performance of the Stock, AstraZeneca PLC currently has a Weekly performance of 5.81%, monthly performance percentage is 2.21 percent, Quarterly performance is 1.65 percent, 6 months performance shows a percent value of 4.79% and Yearly Performance is 12.27 percent.

Company Profile:

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.